By Professor Glenda Halliday

Journal articles

Ahmed RM; Caga J; Devenney E; Hsieh S; Bartley L; Highton-Williamson E; Ramsey E; Zoing M; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2016, 'Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival', Journal of Neurology, 263, pp. 1593 - 1603, http://dx.doi.org/10.1007/s00415-016-8168-2

Schott JM; Crutch SJ; Carrasquillo MM; Uphill J; Shakespeare TJ; Ryan NS; Yong KX; Lehmann M; Ertekin-Taner N; Graff-Radford NR; Boeve BF; Murray ME; Khan QUA; Petersen RC; Dickson DW; Knopman DS; Rabinovici GD; Miller BL; González AS; Gil-Néciga E; Snowden JS; Harris J; Pickering-Brown SM; Louwersheimer E; van der Flier WM; Scheltens P; Pijnenburg YA; Galasko D; Sarazin M; Dubois B; Magnin E; Galimberti D; Scarpini E; Cappa SF; Hodges JR; Halliday GM; Bartley L; Carrillo MC; Bras JT; Hardy J; Rossor MN; Collinge J; Fox NC; Mead S, 2016, 'Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease', Alzheimer's and Dementia, 12, pp. 862 - 871, http://dx.doi.org/10.1016/j.jalz.2016.01.010

Matrone C; Dzamko N; Madsen P; Nyegaard M; Pohlmann R; Søndergaard RV; Lassen LB; Andresen TL; Halliday GM; Jensen PH; Nielsen MS, 2016, 'Mannose 6-phosphate receptor is reduced in -synuclein overexpressing models of parkinsons disease', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0160501

Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH, 2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', Journal of the Neurological Sciences, 366, pp. 197 - 201, http://dx.doi.org/10.1016/j.jns.2016.05.005

Dzamko N; Rowe DB; Halliday GM, 2016, 'Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers', Movement Disorders, 31, pp. 889 - 897, http://dx.doi.org/10.1002/mds.26529

Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2016, 'Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease', PLoS ONE, 11, pp. e0157924, http://dx.doi.org/10.1371/journal.pone.0157924

Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD, 2016, 'MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease', Scientific Reports, 6, http://dx.doi.org/10.1038/srep26697

Mills JD; Ward M; Kim WS; Halliday GM; Janitz M, 2016, 'Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome', Neuroscience, 322, pp. 234 - 250, http://dx.doi.org/10.1016/j.neuroscience.2016.02.042

Postuma RB; Berg D; Adler CH; Bloem BR; Chan P; Deuschl G; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Oertel W; Olanow CW; Poewe W; Stern M, 2016, 'The new definition and diagnostic criteria of Parkinson's disease', The Lancet Neurology, 15, pp. 546 - 548, http://dx.doi.org/10.1016/S1474-4422(16)00116-2

Van der Jeugd A; Vermaercke B; Halliday GM; Staufenbiel M; Götz J, 2016, 'Impulsivity, decreased social exploration, and executive dysfunction in a mouse model of frontotemporal dementia', Neurobiology of Learning and Memory, 130, pp. 34 - 43, http://dx.doi.org/10.1016/j.nlm.2016.01.007

O'Callaghan C; Hornberger M; Balsters JH; Halliday GM; Lewis SJG; Shine JM, 2016, 'Cerebellar atrophy in Parkinson's disease and its implication for network connectivity', Brain, 139, pp. 845 - 855, http://dx.doi.org/10.1093/brain/awv399

Wang G; Huang Y; Wei Chen ; Chen S; Wang Y; Xiao Q; Liu J; Fung VSC; Halliday G; Chen S, 2016, 'Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease', Parkinsonism and Related Disorders, 24, pp. 89 - 94, http://dx.doi.org/10.1016/j.parkreldis.2015.12.018

Bleasel JM; Halliday GM; Kim WS, 2016, 'Animal modeling an oligodendrogliopathy--multiple system atrophy', Acta neuropathologica communications, 4, pp. 12, http://dx.doi.org/10.1186/s40478-016-0279-6

Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM, 2016, 'Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions', Annals of Neurology, 79, pp. 295 - 305, http://dx.doi.org/10.1002/ana.24565

McCann H; Cartwright H; Halliday GM, 2016, 'Neuropathology of α-synuclein propagation and braak hypothesis', Movement Disorders, 31, pp. 152 - 160, http://dx.doi.org/10.1002/mds.26421

Chen AC; Martin AJ; Dalziell RA; McKenzie CA; Lowe PM; Eris JM; Scolyer RA; Dhillon HM; Vardy JL; Bielski VA; Halliday GM; Damian DL, 2016, 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients', British Journal of Dermatology, 175, pp. 1073 - 1075, http://dx.doi.org/10.1111/bjd.14662

Kovacs GG; Ferrer I; Grinberg LT; Alafuzoff I; Attems J; Budka H; Cairns NJ; Crary JF; Duyckaerts C; Ghetti B; Halliday GM; Ironside JW; Love S; Mackenzie IR; Munoz DG; Murray ME; Nelson PT; Takahashi H; Trojanowski JQ; Ansorge O; Arzberger T; Baborie A; Beach TG; Bieniek KF; Bigio EH; Bodi I; Dugger BN; Feany M; Gelpi E; Gentleman SM; Giaccone G; Hatanpaa KJ; Heale R; Hof PR; Hofer M; Hortobágyi T; Jellinger K; Jicha GA; Ince P; Kofler J; Kövari E; Kril JJ; Mann DM; Matej R; McKee AC; McLean C; Milenkovic I; Montine TJ; Murayama S; Lee EB; Rahimi J; Rodriguez RD; Rozemüller A; Schneider JA; Schultz C; Seeley W; Seilhean D; Smith C; Tagliavini F; Takao M; Thal DR; Toledo JB; Tolnay M; Troncoso JC; Vinters HV; Weis S; Wharton SB; White CL; Wisniewski T; Woulfe JM; Yamada M; Dickson DW, 2016, 'Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy', Acta Neuropathologica, 131, pp. 87 - 102, http://dx.doi.org/10.1007/s00401-015-1509-x

Ahmed RM; Irish M; Piguet O; Halliday GM; Ittner LM; Farooqi S; Hodges JR; Kiernan MC, 2016, 'Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism', The Lancet Neurology, 15, pp. 332 - 342, http://dx.doi.org/10.1016/S1474-4422(15)00380-4

Leyton CE; Britton AK; Hodges JR; Halliday GM; Kril JJ, 2016, 'Distinctive pathological mechanisms involved in primary progressive aphasias', Neurobiology of Aging, 38, pp. 82 - 92, http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.017

Burrell JR; Forrest S; Bak TH; Hodges JR; Halliday GM; Kril JJ, 2016, 'Expanding the phenotypic associations of globular glial tau subtypes', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 4, pp. 6 - 13, http://dx.doi.org/10.1016/j.dadm.2016.03.006

Hu Q; Li T; Wang L; Xie Y; Liu S; Bai X; Zhang T; Bo S; Xin D; Xue H; Li G; Wang Z, 2016, 'Neuroprotective Effects of a Smoothened Receptor Agonist against Early Brain Injury after Experimental Subarachnoid Hemorrhage in Rats.', Front Cell Neurosci, 10, pp. 306, http://dx.doi.org/10.3389/fncel.2016.00306

van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CKX; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM, 2015, 'Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration', Neuropathology and Applied Neurobiology, 41, pp. 906 - 925, http://dx.doi.org/10.1111/nan.12233

Devenney E; Bartley L; Hoon C; O'Callaghan C; Kumfor F; Hornberger M; Kwok JB; Halliday GM; Kiernan MC; Piguet O; Hodges JR, 2015, 'Progression in behavioral variant frontotemporal dementia: A longitudinal study', JAMA Neurology, 72, pp. 1501 - 1509, http://dx.doi.org/10.1001/jamaneurol.2015.2061

Leshchyns'Ka I; Liew HT; Shepherd C; Halliday GM; Stevens CH; Ke YD; Ittner LM; Sytnyk V, 2015, 'Aβ-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer's disease', Nature Communications, 6, http://dx.doi.org/10.1038/ncomms9836

Helmfors L; Boman A; Civitelli L; Nath S; Sandin L; Janefjord C; McCann H; Zetterberg H; Blennow K; Halliday G; Brorsson AC; Kågedal K, 2015, 'Protective properties of lysozyme on β-amyloid pathology: Implications for Alzheimer disease', Neurobiology of Disease, 83, pp. 122 - 133, http://dx.doi.org/10.1016/j.nbd.2015.08.024

Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM, 2015, 'Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS', Acta Neuropathologica, 130, pp. 661 - 678, http://dx.doi.org/10.1007/s00401-015-1486-0

Ahmed RM; Latheef S; Bartley L; Irish M; Halliday GM; Kiernan MC; Hodges JR; Piguet O, 2015, 'Eating behavior in frontotemporal dementia', Neurology, 85, pp. 1310 - 1317, http://dx.doi.org/10.1212/WNL.0000000000002018

Rusznák Z; Kim WS; Hsiao JHT; Halliday GM; Paxinos G; Fu YH, 2015, 'Early in vivo effects of the human mutant amyloid-β protein precursor (hAβPPSwInd) on the mouse olfactory bulb', Journal of Alzheimer's Disease, 49, pp. 443 - 457, http://dx.doi.org/10.3233/JAD-150368

Dobson-Stone C; Shaw AD; Hallupp M; Bartley L; McCann H; Brooks WS; Loy CT; Schofield PR; Mather KA; Kochan NA; Sachdev PS; Halliday GM; Piguet O; Hodges JR; Kwok JBJ; Schofield P, 2015, 'Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?', Brain, 138, pp. e385, http://dx.doi.org/10.1093/brain/awv115

Lourenco GF; Janitz M; Huang Y; Halliday GM, 2015, 'Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)', Neurobiology of Disease, 82, pp. 445 - 454, http://dx.doi.org/10.1016/j.nbd.2015.07.011

Murphy KE; Gysbers AM; Abbott SK; Spiro AS; Furuta A; Cooper A; Garner B; Kabuta T; Halliday GM, 2015, 'Lysosomal-associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease', Movement Disorders, 30, pp. 1639 - 1647, http://dx.doi.org/10.1002/mds.26141

Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Obeso J; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G, 2015, 'MDS clinical diagnostic criteria for Parkinson's disease', Movement Disorders, 30, pp. 1591 - 1601, http://dx.doi.org/10.1002/mds.26424

Berg D; Postuma RB; Adler CH; Bloem BR; Chan P; Dubois B; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M; Deuschl G, 2015, 'MDS research criteria for prodromal Parkinson's disease', Movement Disorders, 30, pp. 1600 - 1611, http://dx.doi.org/10.1002/mds.26431

Gabery S; Halliday G; Kirik D; Englund E; Petersén Å, 2015, 'Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: A case study', Neuropathology and Applied Neurobiology, 41, pp. 843 - 848, http://dx.doi.org/10.1111/nan.12236

Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JBJ; Hodges JR; Kiernan MC; Halliday GM, 2015, 'TDP-43 proteinopathies: Pathological identification of brain regions differentiating clinical phenotypes', Brain, 138, pp. 3110 - 3122, http://dx.doi.org/10.1093/brain/awv220

Cordato NJ; Halliday GM, 2015, 'The differentiation of progressive supranuclear palsy', Neurodegenerative disease management, 5, pp. 385 - 388, http://dx.doi.org/10.2217/nmt.15.37

Mccann H; Fung VSC; Klein C; Halliday GM, 2015, 'Unusual α-synuclein and cerebellar pathologies in a case of hereditary myoclonus-dystonia without SGCE mutation', Neuropathology and Applied Neurobiology, 41, pp. 837 - 842, http://dx.doi.org/10.1111/nan.12216

Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K, 2015, 'Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism', Proceedings of the National Academy of Sciences of the United States of America, 112, pp. E5308 - E5317, http://dx.doi.org/10.1073/pnas.1514475112

Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2015, 'Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer’s disease', Current Alzheimer Research, 12, pp. 745 - 751, http://dx.doi.org/10.2174/1567205012666150710110756

Dzamko N; Geczy CL; Halliday GM, 2015, 'Inflammation is genetically implicated in Parkinson's disease', Neuroscience, 302, pp. 89 - 102, http://dx.doi.org/10.1016/j.neuroscience.2014.10.028

Cairns NJ; Perrin RJ; Franklin EE; Carter D; Vincent B; Xie M; Bateman RJ; Benzinger T; Friedrichsen K; Brooks WS; Halliday GM; Mclean C; Ghetti B; Morris JC, 2015, 'Neuropathologic assessment of participants in two multi-center longitudinal observational studies: The Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN)', Neuropathology, 35, pp. 390 - 400, http://dx.doi.org/10.1111/neup.12205

Halliday GM, 2015, 'Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement', Brain, 138, pp. 2116 - 2119, http://dx.doi.org/10.1093/brain/awv151

Fatima M; Tan R; Halliday GM; Kril JJ, 2015, 'Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways', Acta neuropathologica communications, 3, pp. 47, http://dx.doi.org/10.1186/s40478-015-0226-y

Mills JD; Chen J; Kim WS; Waters PD; Prabowo AS; Aronica E; Halliday GM; Janitz M, 2015, 'Long intervening non-coding RNA 00320 is human brain-specific and highly expressed in the cortical white matter', Neurogenetics, 16, pp. 201 - 213, http://dx.doi.org/10.1007/s10048-015-0445-1

Vaikath NN; Majbour NK; Paleologou KE; Ardah MT; van Dam E; van de Berg WDJ; Forrest SL; Parkkinen L; Gai WP; Hattori N; Takanashi M; Lee SJ; Mann DMA; Imai Y; Halliday GM; Li JY; El-Agnaf OMA, 2015, 'Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology', Neurobiology of Disease, 79, pp. 81 - 99, http://dx.doi.org/10.1016/j.nbd.2015.04.009

Ittner LM; Halliday GM; Kril JJ; Götz J; Hodges JR; Kiernan MC, 2015, 'FTD and ALS-translating mouse studies into clinical trials', Nature Reviews Neurology, 11, pp. 360 - 366, http://dx.doi.org/10.1038/nrneurol.2015.65

Shine JM; Mills JMZ; Qiu J; O'Callaghan C; Terpening Z; Halliday GM; Naismith SL; Lewis SJG, 2015, 'Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease', Movement Disorders Clinical Practice, 2, pp. 175 - 181, http://dx.doi.org/10.1002/mdc3.12139

Duyckaerts C; Braak H; Brion JP; Buée L; Del Tredici K; Goedert M; Halliday G; Neumann M; Spillantini MG; Tolnay M; Uchihara T, 2015, 'PART is part of Alzheimer disease', Acta Neuropathologica, 129, pp. 749 - 756, http://dx.doi.org/10.1007/s00401-015-1390-7

Cheshire P; Ayton S; Bertram KL; Ling H; Li A; Mclean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR, 2015, 'Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias', Movement Disorders, 30, pp. 796 - 804, http://dx.doi.org/10.1002/mds.26144

Shine JM; Muller AJ; O'Callaghan C; Hornberger M; Halliday GM; Lewis SJG, 2015, 'Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson's disease: A task-based fMRI study', Parkinson's Disease, 1, http://dx.doi.org/10.1038/npjparkd.2015.3

Back to profile page